Biotherapies in Uveitis
Non-infectious uveitis (NIU) represents one of the leading causes of blindness in developed countries. The therapeutic strategy aims to rapidly control intra-ocular inflammation, prevent irremediable ocular damage, allow corticosteroid sparing and save the vision, and has evolved over the last few y...
Main Authors: | Mathilde Leclercq, Anne-Claire Desbois, Fanny Domont, Georgina Maalouf, Sara Touhami, Patrice Cacoub, Bahram Bodaghi, David Saadoun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/11/3599 |
Similar Items
-
Old and New Challenges in Uveitis Associated with Behçet’s Disease
by: Julie Gueudry, et al.
Published: (2021-05-01) -
Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
by: Jean-Luc Davignon, et al.
Published: (2018-10-01) -
Current standardized therapeutic approach for uveitis in Japan
by: Kazuichi Maruyama
Published: (2019-07-01) -
The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
by: Anji Xiong, et al.
Published: (2021-09-01) -
Biological therapy in refractory cases of uveitis and scleritis: An analysis of 18 cases from a tertiary eye care center from South India
by: Soumen Sadhu, et al.
Published: (2020-01-01)